Downloads
This app helps children undergoing growth hormone treatment
About Fharmaverso
Fharmaverso is an education app developed by MetamedicsVR.
How many times has Fharmaverso been downloaded?
Fharmaverso has been downloaded 38 times. In the last 30 days, the app was downloaded 2 times.
What is the rating of Fharmaverso?
Fharmaverso has no ratings yet.
Is Fharmaverso free?
Fharmaverso is free to download. The APK download size is 160.71 MB. The latest version available is 3.4.3. The last update was on October 8, 2025.
What are the requirements for Fharmaverso?
The app has a content rating of Everyone. The app has been available on Google Play February 2025.
More data about Fharmaverso
| Price | Free to download |
| Total downloads | 38 |
| Recent downloads | 2 |
| Rating | No ratings |
| Ranking | Not ranked |
| Version | 3.4.3 |
| APK size | 160.7 MB |
| Number of libraries | ? |
| Suitable for | Everyone |
| Ads | NO ads |
App Performance Report
Get a detailed PDF report for Fharmaverso with download trends, rating history, and key performance statistics — useful for competitive research or tracking your own app. Learn more
Get PDF Report — $29Alternative downloads for the Fharmaverso app
Fharmaverso compared with similar apps
Common keywords of similar apps
Convierte Miedo Tratamiento Crecimiento Inyecciones En De Cada El Para Los Con Las Una Se Su
Keywords missing from this app
La Tu Cuentos Es Tus Ul Por Te App Esta Dios Dormir Vida Historias Sus Mejor Amor Del Hijos Padres Como Recent Infantiles Al Fe Todo Personas Son Solo Lo Sin Strong Puede
More from MetamedicsVR
Downloads over time
Fharmaverso has been downloaded 38 times. Over the past 30 days, it has been downloaded 2 times.
Changelog of Fharmaverso
Developer information for MetamedicsVR
Comments on Fharmaverso for Android
We don't have enough comments to show example comments. Please check back later.
Google Play Rankings for Fharmaverso
Technologies used by Fharmaverso
Fharmaverso is requesting 2 permissions and we don't have library information (yet).Show details
Back to top